BridgeBio's launch of Attruby in the U.S. is off to a strong start. Read how this successful effort puts the biotech in a ...

Recurrent laryngeal injury risk was reduced with intraoperative nerve monitoring among patients with thyroid cancer undergoing thyroidectomy.

The Food and Drug Administration (FDA) oversees manufacturers of infant formulas and helps ensure that these products are ...

Albumin-adjusted calcium formulas were not associated with greater accuracy in assessing serum calcium levels than unadjusted total calcium.

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby™ have been written by 516 unique prescribers since FDA approval- ...

A HITHERTO infrequently recognized abnormality in patients with osteoblastic metastases is the occurrence of hypocalcemia. It has usually been held that calcium levels are normal in this situation.

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

Anastasia, 27, has defended her relationship with Tiny Texie, from Illinois , Chicago - who was born with Kenny-Caffey ...

Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis and multiple myeloma/bone metastases from solid tumors.

Fresenius Kabi, an operating company of Fresenius, announced today it has introduced Calcitonin Salmon Injection, USP ...

Dystocia may occur with maternal or fetal causes. Maternal causes include primary uterine inertia, birth canal obstruction, uterine torsion or prolapse, and vaginal stricture. Fetal causes include ...

As of February 17, 2025, 1,028 unique patient prescriptions for Attruby have been written by 516 unique prescribers since FDA approval - Attruby (acoramidis), the first and only near-complete TTR ...